Jan 09, 2023 / 09:30PM GMT
Christopher Thomas Schott - JPMorgan Chase & Co, Research Division - Senior Analyst
Good afternoon, everybody. I'm Chris Schott at JPMorgan, and it's my pleasure to be introducing Zoetis today. From the company, we have Kristin Peck, the CEO; as well as Wetteny Joseph, who's going to join us for some of the Q&A after the presentation. As a reminder, we've moved away from the formal breakout sessions at the conference this year. So post the presentation, we're going to do some Q&A from the stage.
And with that, I'm going to turn it over to Kristin. Happy New Year, and thanks for joining us.
Kristin C. Peck - Zoetis Inc. - CEO & Director
All right. Well, it is great to be back. Thank you very much, Chris, especially to be back in person and to see so many familiar faces. Before we get into the real front of the day, we got some legal housekeeping. So why don't I kick into that for a second.
As you can probably imagine, we're going to have some forward-looking statements today as well as financials that are non-GAAP. The
Zoetis Inc at JPMorgan Healthcare Conference Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers